Emend (EE-mend), a new antiemetic

May 2003

You'll hear about Emend (EE-mend), a new antiemetic.

It's the first in a new class...called "substance P blockers."

Substance P is a peptide that's involved in nausea, pain perception, and mood.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Importing drugs from Canada is HUGE
Cardiology You're going to hear a lot more about "aspirin resistance"
Cardiology What do you do when you have a patient getting both an ACE inhibitor AND angiotensin receptor blocker?
Men's Health combining Viagra (sildenafil) with Cardura (doxazosin) and other alpha-blockers
Women's Health Femring, a new estrogen replacement product for postmenopausal women
Natural Medicines Flexium, a new dietary supplement for arthritis
Stroke Risperdal (risperidone) might increase the risk of stroke in dementia patients
Stroke Cozaar (losartan) for preventing stroke
Dermatology The FDA is further restricting the use of lindane for lice.
Hematology & Oncology Emend (EE-mend), a new antiemetic
Hematology & Oncology NSAIDs, folate, or vitamin B6 might reduce the risk of breast cancer
Pediatrics Vitamin D supplements are now recommended for many infants and some children
Seizures Which drugs are most likely to cause seizures?
Ophthalmology two new ophthalmic quinolone antibiotics, Zymar and Vigamox
Ophthalmology bisphosphonates causing eye problems
Neurology & Pain Are some NSAIDs safer for patients with kidney disease?
Practice Patients are asking which masks protect against SARS